Compounds > troglitazone
Page last updated: 2024-11-05

troglitazone and Rhabdomyolysis

troglitazone has been researched along with Rhabdomyolysis in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yokoyama, M1
Izumiya, Y1
Yoshizawa, M1
Usuda, R1

Other Studies

1 other study available for troglitazone and Rhabdomyolysis

ArticleYear
Acute rhabdomyolysis associated with troglitazone.
    Diabetes care, 2000, Volume: 23, Issue:3

    Topics: Chromans; Creatine Kinase; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide;

2000